Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, Van Burgel ND, Van Dam AP, Dessau RB, Fingerle V, Hovius JW, Jaulhac B, Meijer B, Van Pelt W, Schellekens JF, Spijker R, Stelma FF, Stanek G, Verduyn-Lunel F, Zeller H, Sprong H.

BMC Infect Dis. 2016 Mar 25;16:140. doi: 10.1186/s12879-016-1468-4. Review.

2.

Laboratory Diagnosis of Pertussis.

van der Zee A, Schellekens JF, Mooi FR.

Clin Microbiol Rev. 2015 Oct;28(4):1005-26. doi: 10.1128/CMR.00031-15. Review.

3.

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.

Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.

Vaccine. 2013 Aug 12;31(36):3732-8. doi: 10.1016/j.vaccine.2013.05.073. Epub 2013 Jun 3.

PMID:
23742995
4.

Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.

de Greeff SC, de Melker HE, Westerhof A, Schellekens JF, Mooi FR, van Boven M.

Epidemiology. 2012 Nov;23(6):852-60. doi: 10.1097/EDE.0b013e31826c2b9e.

PMID:
23018969
5.

Two-component cluster analysis of a large serodiagnostic database for specificity of increases of IgG antibodies against pertussis toxin in paired serum samples and of absolute values in single serum samples.

de Greeff SC, Teunis P, de Melker HE, Mooi FR, Notermans DW, Elvers B, Schellekens JF.

Clin Vaccine Immunol. 2012 Sep;19(9):1452-6. doi: 10.1128/CVI.00229-12. Epub 2012 Jul 11.

6.

Superior mesenteric artery stent fracture leading to recurrent mesenteric ischemia.

Schellekens JF, Vos JA, van den Heuvel DA, Boersma D, de Vries JP.

Vasc Endovascular Surg. 2011 Oct;45(7):654-9. doi: 10.1177/1538574411414307.

PMID:
21984031
7.

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis.

de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, Mooi FR, Berbers GA.

PLoS One. 2010 Dec 1;5(12):e14183. doi: 10.1371/journal.pone.0014183.

8.

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.

de Vries R, Kretzschmar M, Schellekens JF, Versteegh FG, Westra TA, Roord JJ, Postma MJ.

PLoS One. 2010 Oct 15;5(10):e13392. doi: 10.1371/journal.pone.0013392.

9.

Pertussis disease burden in the household: how to protect young infants.

de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, Notermans DW, Elvers LH, Schellekens JF, de Melker HE.

Clin Infect Dis. 2010 May 15;50(10):1339-45. doi: 10.1086/652281.

PMID:
20370464
10.

Modified onlay technique for the repair of the more complicated incisional hernias: single-centre evaluation of a large cohort.

Poelman MM, Langenhorst BL, Schellekens JF, Schreurs WH.

Hernia. 2010 Aug;14(4):369-74. doi: 10.1007/s10029-010-0646-3. Epub 2010 Mar 14.

11.

Health-related quality of life in patients treated for incisional hernia with an onlay technique.

Poelman MM, Schellekens JF, Langenhorst BL, Schreurs WH.

Hernia. 2010 Jun;14(3):237-42. doi: 10.1007/s10029-009-0619-6. Epub 2010 Jan 9.

PMID:
20063109
12.

Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment.

Chua TC, Saxena A, Schellekens JF, Liauw W, Yan TD, Fransi S, Zhao J, Morris DL.

Ann Surg. 2010 Jan;251(1):101-6. doi: 10.1097/SLA.0b013e3181b5ae43.

PMID:
19838105
13.

[Ingrown toenail].

Schellekens JF, Werson DA, Wille J, de Vries JP.

Ned Tijdschr Geneeskd. 2010;154:A1152. Dutch.

PMID:
20356419
14.

[A midwife involved in patients with puerperal fever in three different hospitals].

Kaan JA, van Dijk Y, Mascini EM, van Kessel RP, Schellekens JF.

Ned Tijdschr Geneeskd. 2008 Oct 11;152(41):2245-8. Dutch.

PMID:
19009813
15.

Evaluation of an in-house cat scratch disease IgM ELISA to detect Bartonella henselae in a routine laboratory setting.

Herremans M, Bakker J, Vermeulen MJ, Schellekens JF, Koopmans MP.

Eur J Clin Microbiol Infect Dis. 2009 Feb;28(2):147-52. doi: 10.1007/s10096-008-0601-8. Epub 2008 Aug 5.

PMID:
18679728
16.

[The control of pertussis after half a century of vaccination].

Niessen WJ, Broer J, Schellekens JF.

Ned Tijdschr Geneeskd. 2008 May 10;152(19):1125; author reply 1125-6. Dutch. No abstract available.

PMID:
18552069
17.

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.

de Greeff SC, Mooi FR, Schellekens JF, de Melker HE.

Pediatr Infect Dis J. 2008 Mar;27(3):218-23. doi: 10.1097/INF.0b013e318161a2b9.

PMID:
18277916
18.

[The obligatory notification of pertussis is not effective for the protection of unvaccinated children].

Niessen WJ, Broer J, Schellekens JF.

Ned Tijdschr Geneeskd. 2008 Jan 12;152(2):86-90. Dutch.

PMID:
18265798
19.

The use of Bartonella henselae-specific age dependent IgG and IgM in diagnostic models to discriminate diseased from non-diseased in Cat Scratch Disease serology.

Herremans M, Vermeulen MJ, Van de Kassteele J, Bakker J, Schellekens JF, Koopmans MP.

J Microbiol Methods. 2007 Nov;71(2):107-13. Epub 2007 Sep 15.

PMID:
17916395
20.

[Invasive Lancefield group A streptococcal infections in the Netherlands].

Vlaminckx BJ, Mascini EM, Schellekens JF.

Ned Tijdschr Geneeskd. 2007 Jul 28;151(30):1669-73. Review. Dutch.

PMID:
17725254
21.

Bordetella pertussis and mixed infections.

Versteegh FG, Mooi-Kokenberg EA, Schellekens JF, Roord JJ.

Minerva Pediatr. 2006 Apr;58(2):131-7.

PMID:
16835573
22.

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M.

J Infect. 2006 Aug;53(2):106-13. Epub 2005 Dec 15.

PMID:
16352342
23.

Estimation of minimum infection rates with Legionella pneumophila in an exposed population.

Boshuizen HC, Nagelkerke NJ, Den Boer JW, De Melker H, Schellekens JF, Peeters MF, Van Vliet H, Conyn-Van Spaendonck MA.

Epidemiol Infect. 2006 Jun;134(3):579-84. Epub 2005 Oct 20.

24.

Community-acquired pathogens associated with prolonged coughing in children: a prospective cohort study.

Versteegh FG, Weverling GJ, Peeters MF, Wilbrink B, Veenstra-van Schie MT, van Leeuwen-Gerritsen JM, Mooi-Kokenberg EA, Schellekens JF, Roord JJ.

Clin Microbiol Infect. 2005 Oct;11(10):801-7.

25.

Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis.

Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JF, Teunis PF.

Epidemiol Infect. 2005 Aug;133(4):737-48.

26.

Pathogen adaptation under imperfect vaccination: implications for pertussis.

van Boven M, Mooi FR, Schellekens JF, de Melker HE, Kretzschmar M.

Proc Biol Sci. 2005 Aug 7;272(1572):1617-24.

27.
28.

[Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].

de Greeff SC, Schellekens JF, Mooi FR, de Melker HE.

Ned Tijdschr Geneeskd. 2005 Apr 23;149(17):937-43. Dutch.

PMID:
15884408
29.

Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994-2003.

Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP, Fernandes T, Bosman A, Schellekens JF.

Clin Microbiol Infect. 2005 Mar;11(3):226-31.

30.

[Doubling of the number of cases of tick bites and lyme borreliosis seen by general practitioners in the Netherlands].

den Boon S, Schellekens JF, Schouls LM, Suijkerbuijk AW, Docters van Leeuwen B, van Pelt W.

Ned Tijdschr Geneeskd. 2004 Apr 3;148(14):665-70. Dutch.

PMID:
15106318
31.

Estimating the incidence of subclinical infections with Legionella Pneumonia using data augmentation: analysis of an outbreak in The Netherlands.

Nagelkerke NJ, Boshuizen HC, de Melker HE, Schellekens JF, Peeters MF, Conyn-van Spaendonck M.

Stat Med. 2003 Dec 30;22(24):3713-24.

PMID:
14673933
32.

Reference values for the SERION classic ELISA for detecting Legionella pneumophila antibodies.

Boshuizen HC, Den Boer JW, de Melker H, Schellekens JF, Peeters MF, van Vliet JA, Conyn-van Spaendonck MA.

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):706-8. Epub 2003 Oct 14. No abstract available.

PMID:
14557924
33.

The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996.

Neppelenbroek SE, De Melker HE, Schellekens JF, Conyn-Van Spaendonck MA.

Euro Surveill. 1999 Dec;4(12):133-134.

PMID:
12631880
34.

Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis.

Teunis PF, van der Heijden OG, de Melker HE, Schellekens JF, Versteegh FG, Kretzschmar ME.

Epidemiol Infect. 2002 Dec;129(3):479-89.

35.

Legionnaires' disease at a Dutch flower show: prognostic factors and impact of therapy.

Lettinga KD, Verbon A, Weverling GJ, Schellekens JF, Den Boer JW, Yzerman EP, Prins J, Boersma WG, van Ketel RJ, Prins JM, Speelman P.

Emerg Infect Dis. 2002 Dec;8(12):1448-54.

36.

[Perinatal pertussis: from mother to child].

Versteegh FG, Schellekens JF, Roord JJ.

Ned Tijdschr Geneeskd. 2002 Feb 23;146(8):387-8. Dutch. No abstract available.

PMID:
11887627
37.

Laboratory-confirmed reinfections with Bordetella pertussis.

Versteegh FG, Schellekens JF, Nagelkerke AF, Roord JJ.

Acta Paediatr. 2002;91(1):95-7.

PMID:
11885549
38.

A model based evaluation of the 1996-7 pertussis epidemic in The Netherlands.

van Boven M, de Melker HE, Schellekens JF, Kretzschmar M.

Epidemiol Infect. 2001 Aug;127(1):73-85.

39.

Subclinical Legionella infection in workers near the source of a large outbreak of Legionnaires disease.

Boshuizen HC, Neppelenbroek SE, van Vliet H, Schellekens JF, den Boer JW, Peeters MF, Conyn-van Spaendonck MA.

J Infect Dis. 2001 Aug 15;184(4):515-8. Epub 2001 Jul 16.

PMID:
11471112
40.

Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG.

Infect Immun. 2001 Aug;69(8):4846-50.

41.

Potentially virulent strains and high colony counts of group A beta-haemolytic streptococci in pharyngitis patients having a delayed recovery or a complication.

Zwart S, Ruijs GJ, Sachs AP, Schellekens JF, de Melker RA.

J Antimicrob Chemother. 2001 May;47(5):689-91.

PMID:
11328786
42.

[An outbreak of scarlet fever, impetigo and pharyngitis caused by the same Streptococcus pyogenes type T4M4 in a primary school].

Hoebe CJ, Wagenvoort JH, Schellekens JF.

Ned Tijdschr Geneeskd. 2000 Nov 4;144(45):2148-52. Dutch.

PMID:
11086489
43.

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.

de Melker HE, Schellekens JF, Neppelenbroek SE, Mooi FR, Rümke HC, Conyn-van Spaendonck MA.

Emerg Infect Dis. 2000 Jul-Aug;6(4):348-57.

44.

Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands.

van Boven M, de Melker HE, Schellekens JF, Kretzschmar M.

Math Biosci. 2000 Apr;164(2):161-82.

PMID:
10748285
45.

Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.

Mascini EM, Jansze M, Schellekens JF, Musser JM, Faber JA, Verhoef-Verhage LA, Schouls L, van Leeuwen WJ, Verhoef J, van Dijk H.

J Infect Dis. 2000 Feb;181(2):631-8.

PMID:
10669348
46.

Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, Schellekens JF.

J Clin Microbiol. 2000 Feb;38(2):800-6.

47.

Clinical evaluation of guidelines and two-test approach for lyme disease.

Blaauw AA, van Loon AM, Schellekens JF, Bijlsma JW.

Rheumatology (Oxford). 1999 Nov;38(11):1121-6.

PMID:
10556266
48.

An epidemic of pertussis among elderly people in a religious institution in The Netherlands.

Mertens PL, Stals FS, Schellekens JF, Houben AW, Huisman J.

Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):242-7.

PMID:
10385011
49.

Group A streptococci: a change in virulence?

Schellekens JF, Schouls LM, van Pelt W, Esveld M, van Leeuwen WJ.

Neth J Med. 1998 Jun;52(6):209-17. No abstract available.

PMID:
9718919
50.

Pitfalls and fallacies of cat scratch disease serology: evaluation of Bartonella henselae-based indirect fluorescence assay and enzyme-linked immunoassay.

Bergmans AM, Peeters MF, Schellekens JF, Vos MC, Sabbe LJ, Ossewaarde JM, Verbakel H, Hooft HJ, Schouls LM.

J Clin Microbiol. 1997 Aug;35(8):1931-7.

Supplemental Content

Loading ...
Support Center